The Complexities of Cannabidiol and Its Effects
A closer look at CBD's effects and risks in health.
Roberto Carlos Andresen Eguiluz, M. I. Montero, P. S. Rajaram, J. E. Z. Alvarado, K. E. McCloskey, R. D. Baxter
― 5 min read
Table of Contents
Cannabis has been a topic of debate for many years due to its mixed effects on health. On one side, it has potential benefits for treating conditions like mental health issues, chronic pain, nausea from chemotherapy, and even some forms of epilepsy. On the other side, it can cause problems like respiratory issues and heart-related events. Because of this mix of effects, countries have different laws about its use. Research is ongoing to learn more about the 550+ chemicals found in cannabis to figure out their safety and effectiveness.
Cannabidiol (CBD) and Its Uses
One of these chemicals is cannabidiol (CBD). Unlike another compound in cannabis called THC, CBD does not cause a "high." Currently, there is an FDA-approved drug called EPIDIOLEX® that uses CBD to treat certain types of epilepsy. Scientists are also looking into how CBD might help with pain management and cancer treatment. They are studying how CBD affects blood vessel growth, inflammation, and blood flow.
Researchers use both animal studies and human cell cultures to investigate CBD's effects. However, many factors, including the amount of drug, how it's taken, and a person's medical history, can influence the results. This makes it hard to draw clear conclusions from different studies.
The Risks of Oxidized Cannabinoids
One area of focus in research is the Toxicity of oxidized cannabinoids, which could contribute to health risks associated with cannabis use. When CBD is exposed to certain conditions, it can change into a more toxic form known as cannabidiol-quinone (CBD-Q). To test this, scientists used two common solvents for their experiments: ethanol and dimethyl sulfoxide (DMSO). They found that CBD can oxidize into CBD-Q when dissolved in these solvents.
In experiments using human cells, the researchers looked at the effects of CBD, CBD-Q, and another stable form called cannabidiol-diacetate (CBD-DA). They tested how these forms affect cell health at two doses: 1 µM and 10 µM. They discovered that CBD-Q was more toxic than both CBD and CBD-DA, with all forms showing increased toxicity at higher doses.
Effects of Different Solvents
To ensure accurate results, the researchers stored CBD and its variants under specific conditions to prevent their degradation. After one month, they tested how stable CBD was when stored in DMSO and ethanol. Their findings showed that CBD in DMSO completely broke down into CBD-Q, while CBD in ethanol also degraded but to a lesser extent. This suggests that CBD is more likely to degrade in DMSO.
Researchers also performed tests to see how easily CBD and CBD-DA could oxidize, confirming that CBD is very sensitive to oxygen. This Oxidation could lead to harmful products like CBD-Q, raising concerns about the conditions under which CBD is stored and tested.
Cell Toxicity Testing
In cell toxicity tests, the scientists followed established techniques to examine the effects of different CBD forms on the health of human blood vessel cells. They treated the cells with solutions of CBD, CBD-Q, and CBD-DA and measured the number of healthy cells after 24 hours. They found that at lower doses (1 µM), the different forms had slight toxicity, but it was only significant in the case of CBD-DA.
At a higher dose (10 µM), all forms showed greater toxicity, with CBD-Q being the most harmful. The doses were compared to control samples, and it was clear that CBD and CBD-Q significantly decreased cell survival compared to the control group. Interestingly, CBD-DA showed better cell survivability at this higher dose.
Comparison of CBD Forms
The researchers also looked at how the two solvents affected the toxicity of the CBD forms. In the DMSO tests, both CBD and CBD-Q led to a considerable drop in cell health compared to the control. However, CBD-DA treated cells showed much better survival rates. The same trend was observed with ethanol solutions, indicating that CBD-DA is less harmful than its counterparts.
Visual inspections of cell images revealed that while CBD and CBD-Q largely eradicated the cells, CBD-DA allowed many cells to remain healthy. However, some differences in cell shape were noted, indicating that even healthy cells could be affected by the treatments.
Importance of Sample Handling
The researchers emphasized the need to carefully handle CBD samples to prevent them from breaking down into CBD-Q, especially in experiments. Because CBD is sensitive to oxygen, proper storage conditions are essential to avoid misleading results about its toxicity. They recommended keeping samples in inert environments and avoiding light and heat exposure, which can lead to degradation.
Additionally, the findings pointed out that how long samples are stored and the conditions they are exposed to could influence experiments. Therefore, it is crucial to maintain strict protocols regarding sample preparation and storage.
Future Directions
Moving forward, the researchers highlighted the importance of developing new CBD forms that resist oxidation and are less toxic. They concluded that understanding how CBD and its variants behave in different storage conditions is crucial for future research, particularly for drug delivery solutions.
By limiting exposure to oxygen and ensuring proper sample handling, future studies can provide clearer insights into the health effects of CBD and related compounds. Overall, this research sheds light on the complexities of cannabis use and the varying impacts of its chemicals on human health.
Title: Cannabidiol Toxicity Driven by Hydroxyquinone Formation
Abstract: Oxidative byproducts of cannabidiol (CBD) are known to be cytotoxic. However, CBD susceptibility to oxidation and resulting toxicity dissolved in two common solvents, ethanol (EtOH) and dimethyl sulfoxide (DMSO), is seldom discussed. Furthermore, CBD products contain a wide range of concentrations, making it challenging to link general health risks associated with CBD cytotoxicity. Here, we report on the effect of CBD and CBD analogs dissolved in EtOH or DMSO at various concentrations. The cells used in these studies were human umbilical vascular endothelial cells (HUVECs). Our findings show that significant CBD oxidation of CBD to form cannabidiol-quinone (CBD-Q) and subsequent cytotoxicity, occurring at 10 {micro}M concentration regardless of the solution delivery vehicle. Moreover, a new analog of CBD, cannabidiol-diacetate (CBD-DA), exhibits significantly more stability and reduced toxicity compared with CBD or CBD-Q. This knowledge is important for determining concentration-dependent health risks of complex cannabinoid mixtures and establishing legal limits.
Authors: Roberto Carlos Andresen Eguiluz, M. I. Montero, P. S. Rajaram, J. E. Z. Alvarado, K. E. McCloskey, R. D. Baxter
Last Update: 2024-10-25 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.10.22.619647
Source PDF: https://www.biorxiv.org/content/10.1101/2024.10.22.619647.full.pdf
Licence: https://creativecommons.org/licenses/by-nc/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.